Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ERV3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA583822
Description
Immunogen sequence: VCYDPKSSPG IWFEIHVGSK EGDLLNQTKV FPSGKDVVSL YFDVCQIVSM GSLFPVIFSS MEYYSSCHKN RYAHPACSTD SPVTTCWDCT TWSTNQQSLG PIMLTKIPLE PDCKTSTCNS VNLTILEPDQ PIWTTGLKAP L.
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro.
Specifications
ERV3 | |
Polyclonal | |
Unconjugated | |
ERV3-1 | |
endogenous retroviral sequence 3; endogenous retrovirus group 3 member 1; endogenous retrovirus group 3 member 1 Env polyprotein; endogenous retrovirus group 3, member 1; Envelope polyprotein; envR; ERV3; ERV3 envelope protein; ERV-3 envelope protein; ERV3-1; ERV3-1 envelope protein; ERVR; ERV-R; ERV-R envelope protein; HERVR; HERV-R; HERV-R envelope protein; HERV-R_7q21.2 provirus ancestral Env polyprotein; SU; Surface protein; TM; Transmembrane protein | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
2086 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q14264 | |
ERV3-1 | |
Recombinant protein corresponding to Human ERV3-1. Recombinant protein control fragment (Product #RP-108371). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction